Objective: To test the hypothesis that once-daily treatment with fluticasone propionate is as effective as twice-daily treatment in children with well controlled asthma. Design: Multicentre ...

The extended-release fluticasone propionate injection (EP-104IAR ... support the possibility of bilateral and repeat dosing.” The study’s generalizability may be limited due to the ...

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology to optimize drug delivery for applications with significant unmet need, ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...

Guidelines on contraindications for lung function tests have been based on expert opinion from >30 years ago. High-risk contraindications to lung function testing are associated with cardiovascular ...

It's not just for writing books no one wants to read and making music no one wants to listen to. As it turns out, it does, provided you limit the scope and keep your expectations in check. Here ...